Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.97−0.01 (-0.72%)
Close on Nov 19, 2026Market cap $18.68MP/E –Yield –
Cocrystal Pharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cocrystal Pharma's free cash flow for the twelve months ending Dec 31, 2025 was -$8.20M. For fiscal 2025 it was -$8.20M. The highest annual figure on record is -$619.03K in fiscal 2010.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.20M | – |
| FY2024 | Dec 31, 2024 | -$16.49M | – |
| FY2023 | Dec 31, 2023 | -$14.78M | – |
| FY2022 | Dec 31, 2022 | -$21.51M | – |
| FY2021 | Dec 31, 2021 | -$12.77M | – |
| FY2020 | Dec 31, 2020 | -$10.07M | – |
| FY2019 | Dec 31, 2019 | -$1.71M | – |
| FY2018 | Dec 31, 2018 | -$8.32M | – |
| FY2017 | Dec 31, 2017 | -$6.94M | – |
| FY2016 | Dec 31, 2016 | -$14.71M | – |
| FY2015 | Dec 31, 2015 | -$10.66M | – |
| FY2014 | Dec 31, 2014 | -$6.02M | – |
| FY2013 | Dec 31, 2013 | -$3.69M | – |
| FY2012 | Dec 31, 2012 | -$1.74M | – |
| FY2011 | Dec 31, 2011 | -$996.38K | – |
| FY2010 | Dec 31, 2010 | -$619.03K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$1.74M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.16M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.12M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.70M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.51M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.39M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.68M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.56M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.16M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.91M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.93M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.41M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.80M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.38M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.08M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.33M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.28M | -214.5% |
| Q4 FY2019 | Dec 31, 2019 | -$1.23M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.44M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.03M | – |
| Q1 FY2019 | Mar 31, 2019 | $1.99M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.99M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.16M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.09M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.08M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.58M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.19M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.09M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.09M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.30M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.16M | – |
See a number that looks wrong?